Page last updated: 2024-10-28

halothane and Atrophy

halothane has been researched along with Atrophy in 2 studies

Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mezin, P1
Payen, JF1
Bosson, JL1
Brambilla, E1
Stieglitz, P1
Harriman, DG1
Sumner, DW1
Ellis, FR1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Implication of Patient in the Making Ready of Recommendations for the Antivitamin K's Gestion in Case of Thrombosis Embolic Venous's Illness. Randomised Study for Clinical Validation.[NCT00227097]300 participants Observational2002-12-31Terminated
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for halothane and Atrophy

ArticleYear
Histological support for the difference between malignant hyperthermia susceptible (MHS), equivocal (MHE) and negative (MHN) muscle biopsies.
    British journal of anaesthesia, 1997, Volume: 79, Issue:3

    Topics: Adolescent; Adult; Aged; Anesthetics, Inhalation; Atrophy; Biopsy; Disease Susceptibility; Female; H

1997
Malignant hyperpyrexia myopathy.
    The Quarterly journal of medicine, 1973, Volume: 42, Issue:168

    Topics: Adolescent; Adult; Anesthesia, General; Atrophy; Biopsy; Child; Child, Preschool; Female; Halothane;

1973